ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000538.1|Nisin_1 # 239 # 412 # 1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.368	BGC0000538.1|Nisin_1 	239	412	+	Loose	1800	21.1718	mdtC	42.86	3000794	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGTACAAAAGATTTTAACTTGGATTTGGTATCTGTTTCGAAGAAAGATTCAGGTGCATCACCACGCATTACAAGTATTTCGCTATGTACACCCGGTTGTAAAACAGGAGCTCTGATGGGTTGTAACATGAAAACAGCAACTTGTAATTGTAGTATTCACGTAAGCAAATAA	MSTKDFNLDLVSVSKKDSGASPRITSISLCTPGCKTGALMGCNMKTATCNCSIHVSK	MKFFALFIYRPVATILLSVAITLCGILGFRMLPVAPLPQVDFPVIIVSASLPGASPETMASSVATPLERSLGRIAGVSEMTSSSSLGSTRIILQFDFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSDTYSQGELYDFASTQLAPTISQIDGVGDVDVGGSSLPAVRVGLNPQALFNQGVSLDDVRTAVSNANVRKPQGALEDGTHRWQIQTNDELKTAAEYQPLIIHYNNGGAVRLGDVATVTDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVDSIRAKLPELQETIPAAIDLQIAQDRSPTIRASLEEVEQTLIISVALVILVVFLFLRSGRATIIPAVSVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENIARHLEAGMKPLQAALQGTREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLLVSLTLTPMMCGWMLKASKPREQKRLRGFGRMLVALQQGYGKSLKWVLNHTRLVGVVLLGTIALNIWLYISIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIRDDPAVDNVTGFTGGSRVNSGMMFITLKPRDERSETAQQIIDRLRVKLAKEPGANLFLMAVQDIRVGGRQSNASYQYTLLSDDLAALREWEPKIRKKLATLPELADVNSDQQDNGAEMNLVYDRDTMARLGIDVQAANSLLNNAFGQRQISTIYQPMNQYKVVMEVDPRYTQDISALEKMFVINNEGKAIPLSYFAKWQPANAPLSVNHQGLSAASTISFNLPTGKSLSDASAAIDRAMTQLGVPSTVRGSFAGTAQVFQETMNSQVILIIAAIATVYIVLGILYESYVHPLTILSTLPSAGVGALLALELFNAPFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRHGNLTPQEAIFQACLLRFRPIMMTTLAALFGALPLVLSGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFSRKPKQTVTE	5.56	gnl|BL_ORD_ID|1212|hsp_num:0	1315			120	198	novobiocin
BGC0000538.1|Nisin_2 # 520 # 3501 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.293	BGC0000538.1|Nisin_2 	520	3501	+	Loose	600	26.9498	ROB-11	23.73	3007125	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	ROB beta-lactamase	ATGATAAAAAGTTCATTTAAAGCTCAACCGTTTTTAGTAAGAAATACAATATTATCTCCAAACGATAAACGGAGTTTTACTGAATATACTCAAGTCATTGAGACTGTAAGTAAAAATAAAGTTTTTTTGGAACAGTTACTACTAGCTAATCCTAAACTCTATAATGTTATGCAGAAATATAATGCTGGTCTGTTAAAGAAGAAAAGGGTTAAAAAATTATTTGAATCTATTTACAAGTATTATAAGAGAAGTTATTTACGATCAACTCCATTTGGATTATTTAGTGAAACTTCAATTGGTGTTTTTTCGAAAAGTTCACAGTACAAGTTAATGGGAAAGACTACAAAGGGTATAAGATTGGATACTCAGTGGTTGATTCGCCTAGTTCATAAAATGGAAGTAGATTTCTCAAAAAAGTTATCATTTACTAGAAATAATGCGAATTATAAGTTTGGAGATCGAGTTTTTCAAGTTTATACCATAAATAGTAGTGAGCTTGAAGAAGTAAATATTAAATATACGAATGTTTATCAAATTATTTCTGAATTTTGTGAGAATGACTATCAAAAATATGAAGATATTTGTGAAACTGTAACCCTTTGCTATGGAGACGAATATAGAGAACTATCGGAACAATATCTTGGCAGTCTGATAGTTAATCATTATTTGATCTCTAATTTACAAAAAGATTTGTTGTCAGATTTTTCTTGGGACACTTTTTTGACTAAAGTTGAAGCAATAGATGAAGATAAAAAATATATAATTCCTCTGAAAAAAGTTCAAAAGTTTATTCAAGAATACTCAGAAATAGAAATTGGTGAAGGTATTGAGAAACTGAAAGAAATATATCAGGAAATGTCACAAATTCTTGAGAATGATAATTATATTCAAATTGATTTAATTAGTGATAGTGAAATAAATTTTGATGTTAAACAAAAGCAACAATTAGAACATTTAGCTGAGTTTTTAGGAAATACGACAAAATCTGTAAGAAGAACATATTTGGATGACTATAAGGATAAATTTATCGAAAAATATGGTGTAGATCAAGAAGTACAAATAACAGAATTATTTGATTCCACATTTGGCATAGGAGCTCCATATAATTATAATCATCCTCGAAATGACTTTTATGAGTCCGAACCGAGTACTCTATACTATTCAGAAGAGGAGAGAGAAAAGTACCTCAGCATGTATGTAGAAGCCGTTAAAAATCATAATGTAATTAATCTTGACGACTTAGAGTCTCATTATCAAAAAATGGACTTAGAAAAGAAAAGTGAACTTCAAGGGTTAGAATTATTTTTGAATTTGGCAAAGGAGTATGAAAAAGATATTTTTATTTTAGGGGATATCGTTGGAAATAATAATTTGGGAGGGGCATCAGGTAGATTTTCTGCACTCTCTCCGGAGTTAACAAGTTATCATAGAACGATAGTAGATTCTGTCGAAAGAGAAAATGAGAATAAAGAAATTACATCGTGTGAAATAGTATTTCTTCCAGAAAATATCAGACATGCTAACGTTATGCATACATCAATTATGAGGAGGAAAGTACTTCCATTTTTTACAAGTACAAGTCACAATGAAGTTCAGTTAACTAATATCTATATTGGAATAGACGAAAAAGAAAAATTTTATGCACGAGACATTTCAACTCAAGAGGTATTGAAATTCTACATTACAAGCATGTACAATAAAACGTTATTCAGTAATGAGCTAAGATTTCTTTACGAAATTTCATTAGATGACAAGTTTGGTAATTTACCTTGGGAACTTATTTACAGAGACTTTGATTATATTCCACGTTTAGTATTTGACGAAATAGTAATATCTCCTGCTAAATGGAAAATTTGGGGAAGGGATGTAAATAATAAGATGACAATAAGAGAACTTATTCAAAGCAAAGAAATTCCCAAAGAGTTTTATATTGTCAATGGAGATAATAAAGTTTATTTATCACAGGAAAACCCATTGGATATGGAAATTTTAGAGTCGGCGATAAAGAAGAGCTCAAAAAGAAAAGATTTTATAGAGCTACAAGAATATTTTGAAGATGAAAATATCATAAATAAAGGACAAAAGGGGAGAGTTGCCGATGTTGTAGTGCCTTTCATTAGAACGAGAGCATTAGGTAATGAAGGGAGAGCATTTATAAGAGAGAAAAGAGTTTCGGTTGAACGGCGTGAAAAACTGCCCTTTAACGAGTGGCTTTATCTCAAGTTGTACATTTCTATAAATCGTCAAAATGAATTTTTACTGTCGTATCTTCCAGATATTCAGAAAATAGTAGCAAACCTGGGTGGAAAACTATTCTTCCTAAGATATACTGATCCTAAACCACATATTAGATTGCGTATAAAATGTTCAGATTTATTTTTAGCTTACGGATCTATTCTTGAAATCTTAAAAAGGAGTCAGAAAAATAGGATAATGTCAACTTTTGATATTTCTATTTATGATCAAGAAGTAGAAAGATATGGTGGATTTGATACTTTAGAGTTATCCGAAGCAATATTTTGTGCCGATTCTAAAATTATTCCAAATTTGCTTACATTGATAAAAGATACTAATAATGATTGGAAAGTCGATGATGTATCAATCTTGGTGAATTATTTATATCTGAAATGCTTCTTTCAGAATGATAACAAAAAGATTCTTAATTTTTTGAATTTAGTTAGTCCTAAAAAGGTTAAAGAAAATGTCAATGAAAAGATTGAACATTATCTTAAACTTCTGAAAGTTGATAATCTAGGTGACCAAATTTTTTATGACAAGAATTTTAAAGAATTAAAGCATGCCATAAAAAATTTATTTTTAAAAATGATAGCTCAAGATTTTGAACTTCAGAAAGTTTATTCAATTATTGACAGTATCATTCATGTCCATAATAACCGACTAATTGGTATTGAACGAGATAAAGAGAAATTAATTTATTACACACTTCAAAGGTTGTTTGTTTCGGAAGAATACATGAAATGA	MIKSSFKAQPFLVRNTILSPNDKRSFTEYTQVIETVSKNKVFLEQLLLANPKLYNVMQKYNAGLLKKKRVKKLFESIYKYYKRSYLRSTPFGLFSETSIGVFSKSSQYKLMGKTTKGIRLDTQWLIRLVHKMEVDFSKKLSFTRNNANYKFGDRVFQVYTINSSELEEVNIKYTNVYQIISEFCENDYQKYEDICETVTLCYGDEYRELSEQYLGSLIVNHYLISNLQKDLLSDFSWDTFLTKVEAIDEDKKYIIPLKKVQKFIQEYSEIEIGEGIEKLKEIYQEMSQILENDNYIQIDLISDSEINFDVKQKQQLEHLAEFLGNTTKSVRRTYLDDYKDKFIEKYGVDQEVQITELFDSTFGIGAPYNYNHPRNDFYESEPSTLYYSEEEREKYLSMYVEAVKNHNVINLDDLESHYQKMDLEKKSELQGLELFLNLAKEYEKDIFILGDIVGNNNLGGASGRFSALSPELTSYHRTIVDSVERENENKEITSCEIVFLPENIRHANVMHTSIMRRKVLPFFTSTSHNEVQLTNIYIGIDEKEKFYARDISTQEVLKFYITSMYNKTLFSNELRFLYEISLDDKFGNLPWELIYRDFDYIPRLVFDEIVISPAKWKIWGRDVNNKMTIRELIQSKEIPKEFYIVNGDNKVYLSQENPLDMEILESAIKKSSKRKDFIELQEYFEDENIINKGQKGRVADVVVPFIRTRALGNEGRAFIREKRVSVERREKLPFNEWLYLKLYISINRQNEFLLSYLPDIQKIVANLGGKLFFLRYTDPKPHIRLRIKCSDLFLAYGSILEILKRSQKNRIMSTFDISIYDQEVERYGGFDTLELSEAIFCADSKIIPNLLTLIKDTNNDWKVDDVSILVNYLYLKCFFQNDNKKILNFLNLVSPKKVKENVNEKIEHYLKLLKVDNLGDQIFYDKNFKELKHAIKNLFLKMIAQDFELQKVYSIIDSIIHVHNNRLIGIERDKEKLIYYTLQRLFVSEEYMK	MLNKLKIGTLLLLTLTACSPNSVHSVTSNPQPASAPVQQSATQATFQQTLANLEQQYQARIGVYVWDTETGHSLSYRADERFAYASTFKALLAGAVLQSLPEKDLNRTISYSQKDLVSYSPETQKYVGKGMTIAQLCEAAVRFSDNSATNLLLKELGGVEQYQRILRQLGDNVTHANRLEPDLNQAKPNDIRDTSTPKQMAMNLNAYLLGNTLTESQKTILWNWLDNNATGNPLIRAATPTSWKVYDKSGAGKYGVRNDIAVVRIPNRKPIVMAIMSTQFTEEAKFNNKLVEDAAKQVFHTLQLN	325.57	gnl|BL_ORD_ID|4804|hsp_num:0	5795			714	891	
BGC0000538.1|Nisin_3 # 3512 # 5314 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.306	BGC0000538.1|Nisin_3 	3512	5314	+	Loose	1000	133.265	msbA	24.76	3003950	protein homolog model	n/a	n/a	nitroimidazole antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGATGAAGTGAAAGAATTCACATCAAAACAATTTTTTAATACTTTACTTACTCTTCCAAGCACCTTGAAGTTAATTTTTCAGTTGGAAAAACGTTATGCAATTTATTTAATTGTGCTAAATGCTATCACAGCTTTTGTTCCGTTGGCTAGTCTTTTTATTTATCAAGATTTAATAAACTCTGTGCTAGGTTCAGGGAGACATCTTATCTATATTATTATCATCTATTTTATTGTTCAAGTGATAACAACAGTTCTGGGACAGCTGGAAAGTTATGTTAGTGGAAAATTTGATATGCGACTTTCTTACAGTATCAATATGCGCCTCATGAGGACTACCTCATCTCTTGAATTAAGTGATTATGAGCAGGCTGATATGTATAATATCATAGAAAAAGTTACTCAAGACAGCACTTACAAGCCTTTTCAGCTATTTAATGCTATCATTGTTGTGCTTTCATCGTTTATCTCATTGCTATCTAGTCTATTTTTTATTGGAACATGGAACATTGGGGTAGCAATTTTACTCCTTATTGTTCCAGTATTATCTTTGGTACTTTTTCTCAGAGTGGGACAATTAGAGTTTTTAATCCAGTGGCAGAGAGCAAGTTCTGAAAGAGAAACATGGTATATTGTATATTTATTGACTCATGATTTTTCATTTAAAGAAATCAAATTAAATAATATTAGCAATTACTTCATTCATAAATTTGGAAAATTAAAGAAAGGATTTATCAACCAAGATTTAGCTATTGCTCGTAAGAAGACATATTTCAATATTTTTCTTGATTTCATTTTGAATTTGATAAATATTCTTACGATATTTGCTATGATCCTTTCGGTAAGAGCAGGAAAACTTCTTATAGGTAATTTGGTAAGTCTCATACAAGCTATTTCTAAAATCAATACTTATTCTCAAACAATGATTCAAAATATTTACATCATTTATAATACTAGTTTGTTTATGGAACAACTTTTTGAGTTTTTAAAGAGAGAAAGTGTAGTTCACAAAAAAATAGAAGATACTGAAATATGCAATCAAGATATAGGAACTGTTAAAGTAATTAATTTATCATATGTTTACCCTAATTCGAATGCCTTTGCACTAAAGAATATCAATTTATCCTTTGAAAAAGGAGAATTAGCTGCTATTGTAGGAAAAAATGGTTCCGGGAAAAGTACACTAGTAAAGATAATTTCAGGATTATATCAACCAACTATGGGAATAATCCAATACGACAAAATGAGAAATAGTTTGATGCCTGAGGAGTTTTATCAGAAAAACATATCGGTGCTGTTCCAAGATTTTGTGAAGTATGAGTTAACGATAAGAGAGAATATAGGATTGAGTGATTTGTCTTCTCAATGGGAAGATGAGAAAATTATTAAAGTACTAGATAATTTAGGACTCGATTTTTTGAAAACTAATAATCAATATGTACTTGATACGCAGTTAGGAAATTGGTTTCAAGAAGGGCGTCAACTTTCAGGAGGTCAGTGGCAAAAAATTGCATTAGCAAGGACATTTTTTAAGAAAGCTTCAATTTATATTTTAGATGAACCAAGTGCTGCACTCGATCCTGTAGCTGAAAAAGAAATATTTGATTATTTTGTTGCTCTTTCGGAAAATAATATTTCAATTTTCATTTCTCATAGTTTGAATGCTGCCAGAAAAGCAAATAAAATCGTGGTTATGAAAGATGGACAGGTCGAAGATGTTGGAAGTCATGATGTCCTTCTGAGAAGATGTCAATACTATCAAGAACTTTATTATTCAGAGCAATATGAGGATAATGATGAATAA	MDEVKEFTSKQFFNTLLTLPSTLKLIFQLEKRYAIYLIVLNAITAFVPLASLFIYQDLINSVLGSGRHLIYIIIIYFIVQVITTVLGQLESYVSGKFDMRLSYSINMRLMRTTSSLELSDYEQADMYNIIEKVTQDSTYKPFQLFNAIIVVLSSFISLLSSLFFIGTWNIGVAILLLIVPVLSLVLFLRVGQLEFLIQWQRASSERETWYIVYLLTHDFSFKEIKLNNISNYFIHKFGKLKKGFINQDLAIARKKTYFNIFLDFILNLINILTIFAMILSVRAGKLLIGNLVSLIQAISKINTYSQTMIQNIYIIYNTSLFMEQLFEFLKRESVVHKKIEDTEICNQDIGTVKVINLSYVYPNSNAFALKNINLSFEKGELAAIVGKNGSGKSTLVKIISGLYQPTMGIIQYDKMRNSLMPEEFYQKNISVLFQDFVKYELTIRENIGLSDLSSQWEDEKIIKVLDNLGLDFLKTNNQYVLDTQLGNWFQEGRQLSGGQWQKIALARTFFKKASIYILDEPSAALDPVAEKEIFDYFVALSENNISIFISHSLNAARKANKIVVMKDGQVEDVGSHDVLLRRCQYYQELYYSEQYEDNDE	MHNDKDLSTWQTFRRLWPTIAPFKAGLIVAGVALILNAASDTFMLSLLKPLLDDGFGKTDRSVLVWMPLVVIGLMILRGITSYVSSYCISWVSGKVVMTMRRRLFGHMMGMPVSFFDKQSTGTLLSRITYDSEQVASSSSGALITVVREGASIIGLFIMMFYYSWQLSIILIVLAPIVSIAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLIFGGQEVETKRFDKVSNRMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMDSLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFTILDSEQEKDEGKRVIERATGDVEFRNVTFTYPGRDVPALRNINLKIPAGKTVALVGRSGSGKSTIASLITRFYDIDEGEILMDGHDLREYTLASLRNQVALVSQNVHLFNDTVANNIAYARTEQYSREQIEEAARMAYAMDFINKMDNGLDTVIGENGVLLSGGQRQRIAIARALLRDSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLSTIEKADEIVVVEDGVIVERGTHNDLLEHRGVYAQLHKMQFGQ	103.09	gnl|BL_ORD_ID|2185|hsp_num:0	2423			267	1728	metronidazole
BGC0000538.1|Nisin_4 # 5307 # 6551 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.316	BGC0000538.1|Nisin_4 	5307	6551	+	Loose	750	26.5646	mefE	29.63	3000614	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAATAAAAAAAATATAAAAAGAAATGTTGAAAAAATTATTGCTCAATGGGATGAGAGAACTAGAAAAAATAAAGAAAACTTCGATTTCGGAGAGTTGACTCTCTCTACAGGATTGCCTGGTATAATTTTAATGTTAGCGGAGTTAAAAAATAAAGATAACTCAAAGATATATCAGAAAAAGATAGACAATTATATTGAATATATTGTTAGCAAACTTTCAACATATGGGCTTTTAACAGGATCGCTTTATTCGGGAGCAGCTGGCATTGCATTAAGTATCCTACATTTACGAGAAGATGACGAAAAATATAAGAATCTTCTTGACAGCCTAAATAGATATATCGAATATTTCGTCATAGAAAAAATTGAAGGGTTTAATTTGGAAAACATTACTCCTCCTGATTATGACGTGATTGAAGGTTTATCTGGGATACTTTCCTATCTATTATTAATCAACGACGAGCAATATGATGATTTGAAAATACTCATTATCAATTTTTTATCAAATCTGACTAAAGAAAACAAAGGACTAATATCGCTTTACATCAAATCGGAGAATCAGATGTCTCAATCAGAAAGTGAGATGTATCCACTAGGCTGTTTGAATATGGGATTAGCACATGGACTTGCTGGAGCGGGCTGTATCTTAGCTTATGCCCACATAAAAGGATATAGTAATGAAGCCTCGTTGTCAGCTTTGCAAAAAATTATTTTTATTTATGAAAAGTTTGAACTTGAAATTAAAAATCAGTTTCTATGGAAAGATGGACTTGTAGCAGATGAATTAAAAAAAGAGAAAGTAATTAGGGAAGCAAGTTTCATTAGAGATGCATGGTGCTATGGAGGTCCAGGTATTAGTCTGCTATACTTATACGGAGGATTAGCACTGGATAATGACTATTTTGTAGATAAAGCAGAAAAAATATTAGAGTCAGCTATGCAAAGAAAACTTGGTATTGATTCATATATGATTTGCCATGGCTATTCTGGTTTAATAGAAATTTGTTCTTTATTTAAGCGGCTATTAAATACAAAAAAGTTTGATTCATACATAGAAGAATTTAATGTTAATAGTGAGCAAATTCTTGAAGAATACGGAGATGAAAGTGGCACGGGTTTTCTTGAAGGAATAAGTGGCTGTATACTGGTATTATCGAAATTTGAATATTCAATCAATTTTACTTATTGGAGACAAGCACTGTTACTTTTTGATGATTTTTTGAAAGGAGGGAAGAGGAAATGA	MNKKNIKRNVEKIIAQWDERTRKNKENFDFGELTLSTGLPGIILMLAELKNKDNSKIYQKKIDNYIEYIVSKLSTYGLLTGSLYSGAAGIALSILHLREDDEKYKNLLDSLNRYIEYFVIEKIEGFNLENITPPDYDVIEGLSGILSYLLLINDEQYDDLKILIINFLSNLTKENKGLISLYIKSENQMSQSESEMYPLGCLNMGLAHGLAGAGCILAYAHIKGYSNEASLSALQKIIFIYEKFELEIKNQFLWKDGLVADELKKEKVIREASFIRDAWCYGGPGISLLYLYGGLALDNDYFVDKAEKILESAMQRKLGIDSYMICHGYSGLIEICSLFKRLLNTKKFDSYIEEFNVNSEQILEEYGDESGTGFLEGISGCILVLSKFEYSINFTYWRQALLLFDDFLKGGKRK	MKIDKKNEAFLIVSRGISRIGDIMFDFANNTFLAGLNPTSLSLVAVYQSLESVIGVLFNLFGGVIADSFKRKKIIIVANILCGIACIILSFISQEQWMVFAIVITNIILAFMSAFSGPSYKAFTKEIVKKDSISQLNSLLEITSTIIKVTIPMVAILLYKLLGIHGVLLLDGFSFLIAASLISFIVPVNDEVVTKDKMTIGGVLNDLKIGFKYIYSHKTIFMIIILSAFVNFFLAAYNLLLPYSNQMFGEISDGLYGVFLTAEAIGGFIGAILSGVINKTLSSKRLMVFLSCSGLMLMLSTPLYFLFQNFIILAFSPALFSLFISIFNIQFFSIVQREVDTEFLGRVFGIIFTVAILFMPVGSGFFSVVLNPNNTFNLFIIGVSITILSLIFSTLLKRYDKNS	102.73	gnl|BL_ORD_ID|1283|hsp_num:0	1401			108	258	
BGC0000538.1|Nisin_5 # 6548 # 7285 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.339	BGC0000538.1|Nisin_5 	6548	7285	+	Loose	2200	28.1054	rpoB2	26.25	3000501	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	ATGAGAAAATATTTAATACTTATTGTGGCCTTAATAGGGATAACAGGTTTATCAGGGTGTTATCAAACAAGTCAAAAAAAGGTGAGGTTTGACGAAGGAAGTTATACTAATTTTATTTATGATAATAAATCGTATTTCGTAACTGATAAGGAGATTCCTCAGGAGAACGTTAACAATTGCAAAGTAAAATTTTATAACCTGTTGATTGTTGACATGAAAAGTGAGAAACTTTTATCAAGTAGCAACAAAAATAGTGTGACTTTGGTCTTAAATAATATTTATGAGGCTTCTGACAAGTCGCTATGTATGGGTATTAACGACAGATACTATAAGATACTTCCAGAAAGTGATAAGGGGGTGGTCAAAGCTTTGAGATTACAAAACTTTGATGTGACAAGCGATATTTCTGATGATAATTTTGTTATTGATAAAAATGATTCACGAAAAATTGACTATATGGGAAATATTTACAGTATATCGGACACCACCGTATCTGATGAAGAATTGGGAGAATATCAGGATGTTTTAGCTGAAGTACGTGTGTTTGATTCAGTTAGTGGCAAAAGTATCCCGAGGTCTGAATGGGGGAGAATTGATAAGGATGGTTCAAATTCTAAACAGAGTAGGACGGAATGGGATTATGGCGAAATCCATTCTATTAGAGGAAAATCTCTTACTGAAGCATTTGCCGTTGAGATAAATGATGATTTTAAGCTTGCAACGAAGGTAGGAAACTAG	MRKYLILIVALIGITGLSGCYQTSQKKVRFDEGSYTNFIYDNKSYFVTDKEIPQENVNNCKVKFYNLLIVDMKSEKLLSSSNKNSVTLVLNNIYEASDKSLCMGINDRYYKILPESDKGVVKALRLQNFDVTSDISDDNFVIDKNDSRKIDYMGNIYSISDTTVSDEELGEYQDVLAEVRVFDSVSGKSIPRSEWGRIDKDGSNSKQSRTEWDYGEIHSIRGKSLTEAFAVEINDDFKLATKVGN	MLEGRIVTVSSRTESPLAAPGVPGAPRRLSFARIREPLAVPGLLDIQTESFGWLIGAPDWCARAAARGTEPVAGLAEVLAEISPIEDFAGTMSLTLSDPRFEEVKASVEECKDKDLTYAAPWFVTAEFVNNNTGEIKSQTVFMGDFPMMTAHGTFVVNGTERVVVSQLVRSPGVYFDHAIDKGSEKDVHSARVIPSRGAWLEFDVDKRDTLGVRIDRKRRQPVTVLLKALGWSAERIAERFGFAPLIMASLAKDNVAGTDDALLEIHRKLRPGEPPTKESAQNLLANLFFTEKRYDLARVGRYKIDKKLGLRAPGAPRVLTEDDIAATIEYLVRLHAGERTMIAPGGVEVPVEVDDIDHFGNRRVRTVGELIQNQIRVGLSRMERVVRERMTTQDVEAITPQSLMNIRPVVAAMKEFFGTSQLSQFMDQRNPLASLTNKRRLSALGPGGLSRERAGLEVRDVHYSHYGRMCPIETPEGPNIGLMGYLSVYARVNPFGFVETPYRRVVDGRVTDEVDYLTADEEDRHVVAQANEPLDAEGRFLAARIPVRRKNSEVELVDSAAVDYMDVSPRQMVSVATAMIPFLEHDDANRALMGANMQRQAVPLIRSEAPIVGTGMELRAAVDAGDVVVNEKAGVVEEVSADYVTVMADDGTRKSYRMRKFNRSNQGTCSNQRPIVDEGQRVEAGQVLADGPCTENGEMALGKNLLVAIMPWEGHNYEDAIILSQRLVEQDVLTSIHIEEHEIDARDTKLGAEEITRDIPNVSDEVLADLDERGIVRIGAEVRDGDILVGKVTPKGETELTPEERLLRAIFGEKAREVRDTSLKVPHGESGKVIGIRVFSREDDDDLPPGVNELVRVYVAQKRKIQDGDKLAGRHGNKGVIGKILPTEDMPFLPDGTPVDIILNTHGVPRRMNIGQILETHLGWIGKAGWKVEGNPEWAKDLPEEMWEAPADSNIATPVFDGAREEELTGLLGSTLPNRDGERMVDDNGKAVLFDGRSGEPFPYPVAVGYMYILKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMECWAMQAYGAAYTLQELLTIKSDDVVGRVKVYEAIVKGDNIPEPGVPESFKVLLKELQALCLNVEVLSAGAAVELAHGVDDDHERTAANLGINLSRAESITETELSG	21.08	gnl|BL_ORD_ID|2431|hsp_num:0	2831			2154	2394	rifampin; rifaximin; rifabutin; rifapentine
BGC0000538.1|Nisin_6 # 7287 # 7610 # 1 # ID=1_6;partial=01;start_type=GTG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.346	BGC0000538.1|Nisin_6 	7287	7610	+	Loose	400	25.7942	ErmX	31.03	3000596	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	GTGAAAAAAATACTAGGTTTCCTTTTTATCGTTTGTTCGTTGGGTTTATCAGCAACTGTGCATGGGGAGACAACAAATTCACAACAGTTACTCTCAAATAATATTAATACGGAATTAATTAATCATAATTCTAATGCAATTTTATCTTCAACAGAGGGATCAACGACTGATTCGATTAATCTAGGGGAGCAGTCAACTGCAGTAAAATCGACAACAAGGACTGAATTGGATGTAACTGGTGCTGCTAAAACTTTATTACAGACATCAGCTGTTCAAAAAGAAATGAAAGTTTCGTTGCAAGAAACTCAAGTTAGTTCTGAATTC	MKKILGFLFIVCSLGLSATVHGETTNSQQLLSNNINTELINHNSNAILSSTEGSTTDSINLGEQSTAVKSTTRTELDVTGAAKTLLQTSAVQKEMKVSLQETQVSSEF	MSAYGQGRHEHGQNFLTNHKIINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAVEVDAKLAAKITQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAWTDAVLLMQWEVARRRAGVGATTMMTAQWSPWFTFHLGSRVPRSAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRQGCFHHVQKHNHGCAREESTPRPYLPDCYTNDWIDLFQVTGSSLPHHRPISPSGSSQRPPQRKNRSRRR	38.03	gnl|BL_ORD_ID|872|hsp_num:0	950			0	243	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
